QA: Corcept Therapeutics INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001088856_2012_Corcept_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001088856, Corcept Therapeutics INC

  xvar xval
0 AssetsCurrent 39,775,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 26,000
3 remainder_Assets 32,000
4 LiabilitiesCurrent 5,026,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 60,581,000
9 ResearchAndDevelopmentExpense 154,161,000
10 remainder_Expenses 1,655,000
11 remainder_Revenues 7,839,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 39,833,000
1 Liabilities 5,026,000
2 Expenses 216,397,000
3 Revenues 7,839,000
4 StockholdersEquity 34,807,000
5 NetIncome -208,558,000
6 ComprehensiveNetIncome -208,558,000
7 BaseVar 134,547,500
8 EconomicCapitalRatiobeforeLimitedLiability -5.92
9 EconomicCapitalRatio 0.0858

Edgar->Model Mapping

Feature Distribution